RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA
Clinical trials for RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA explained in plain language.
Never miss a new study
Get alerted when new RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA trials appear
Sign up with your email to follow new studies for RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental drug AMG 420 tested in advanced blood cancer – trial halted early
Disease control TerminatedThis early-stage trial tested a drug called AMG 420 in 23 people with multiple myeloma, a type of blood cancer, that had come back or stopped responding to prior treatments. The goal was to find the safest dose and check for side effects. The study was stopped early, and results …
Matched conditions: RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA
Phase: PHASE1 • Sponsor: Amgen • Aim: Disease control
Last updated May 26, 2026 12:07 UTC
-
Promising myeloma combo trial halted after just 2 patients
Disease control TerminatedThis early-stage study tested a new oral drug (narazaciclib) combined with a steroid (dexamethasone) in people with multiple myeloma that had come back or stopped responding to other treatments. The goal was to find a safe, effective dose and check for side effects. Only 2 people…
Matched conditions: RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA
Phase: PHASE1, PHASE2 • Sponsor: Adriana Rossi • Aim: Disease control
Last updated May 26, 2026 12:07 UTC